Cream to Treat Anal Fissures Meets Late-Stage Goal

Cream to Treat Anal Fissures Meets Late-Stage Goal

Print This Email this  

36% of US physicians said that they have minimal to no savings.

See what else our Physician Lifestyle Report reveals about family life, spending habits, religious beliefs, and more. View report >

(Reuters) May 14 – Drugmaker Ventrus Biosciences Inc said its cream to treat anal fissures met the main goal of reducing pain in a late-stage trial.

The cream, diltiazem hydrochloride, was tested on 465 patients with anal fissures – tears in the anal lining that can cause severe anal pain, associated with or after bowel movements.

Codenamed VEN 307, the cream is being developed with Ventrus’ partner S.L.A. Pharma.

Ventrus said it plans to meet with the U.S. Food and Drug Administration to discuss the steps toward filing for approval.

via Cream to Treat Anal Fissures Meets Late-Stage Goal.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s